Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.2 USD | +1.30% | -7.72% | -16.09% |
May. 21 | JPMorgan Starts Structure Therapeutics With Overweight Rating | MT |
May. 09 | Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 22.22M | Capitalization | 1.59B |
---|---|---|---|---|---|
Net income 2024 * | -134M | Net income 2025 * | -157M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M | Net cash position 2025 * | 156M | EV / Sales 2025 * | 64.7 x |
P/E ratio 2024 * |
-38.4
x | P/E ratio 2025 * |
-30.8
x | Employees | 93 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.06% |
1 day | +1.30% | ||
1 week | -7.72% | ||
1 month | -13.29% | ||
3 months | -15.70% | ||
6 months | -38.59% | ||
Current year | -16.09% |
Managers | Title | Age | Since |
---|---|---|---|
Raymond Stevens
FOU | Founder | 60 | 19-01-31 |
Jun Yoon
DFI | Director of Finance/CFO | 46 | 19-01-31 |
Ying Li Ma
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Tetlow
BRD | Director/Board Member | 64 | 22-03-28 |
Ted Love
BRD | Director/Board Member | 65 | 23-08-02 |
Eric Dobmeier
BRD | Director/Board Member | 55 | 22-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 34.2 | +1.30% | 835,811 |
24-05-30 | 33.76 | -6.79% | 660,485 |
24-05-29 | 36.22 | -2.32% | 293,652 |
24-05-28 | 37.08 | +0.05% | 337,085 |
24-05-24 | 37.06 | -3.29% | 507,177 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.09% | 1.59B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- GPCR Stock